Jake L. Netterville is Director at AMEDISYS INC (AMED). They have made 6 open-market trades across 1 company since 2017, most recently 2019-12-10.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMED | 71,700 | $7.2M |
Shares reported on the most recent Form 4, priced at the 2019-12-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2019-12-10 | 2019-12-12 | $167.56 | $168K | -0.4% | +8.2% | +4.5% |
| AMED | SELL | 2019-09-06 | 2019-09-10 | $135.64 | $136K | +1.3% | -4.0% | +24.3% |
| AMED | SELL | 2019-06-13 | 2019-06-17 | $118.17 | $440K | -0.1% | +5.3% | +9.3% |
| AMED | SELL | 2018-11-15 | 2018-11-19 | $122.21 | $707K | +14.0% | -4.5% | +11.0% |
| AMED | SELL | 2018-06-12 | 2018-06-13 | $80.44 | $659K | +4.6% | +14.4% | +52.1% |
| AMED | SELL | 2017-05-12 | 2017-05-15 | $60.00 | $600K | +0.1% | +6.1% | -17.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.